Literature DB >> 6401839

Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).

O D Ratnoff, J E Menitove, R H Aster, M M Lederman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401839     DOI: 10.1056/NEJM198302243080808

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Expression of CD4 by human megakaryocytes.

Authors:  R S Basch; Y H Kouri; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.

Authors:  Michael Nardi; Steven J Feinmark; Liang Hu; Zongdong Li; Simon Karpatkin
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.

Authors:  M A Nardi; L X Liu; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Adrenocortical function in the acquired immunodeficiency syndrome (AIDS)

Authors:  E G Biglieri
Journal:  West J Med       Date:  1988-01

5.  Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.

Authors:  J R Yu; E T Lennette; S Karpatkin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

6.  The epidemiology of immune thrombocytopenia.

Authors:  W F Schlech; C Nesdoly; N Meagher; J Turner; D Dickey
Journal:  Can J Infect Dis       Date:  1992-11

7.  Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.

Authors:  Zongdong Li; Michael A Nardi; Simon Karpatkin
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

8.  Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacs.

Authors:  M Katzman; M M Lederman
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Hemophilia and thrombocytopenia in a patient with impaired cellular immunity. A case report.

Authors:  U Zeitlhuber; F Haschke; R Püspök; K Lechner; W Knapp; P Imbach
Journal:  Blut       Date:  1984-06

10.  Chronic immune thrombocytopenic purpura in hemophilia A.

Authors:  B S Reen; R T Card; J B McSheffrey; L F Skinnider
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.